Company Valuation: Organo Corporation

Data adjusted to current consolidation scope
Fiscal Period: March 2022 2023 2024 2025 2026 2027 2028 2029
Market Cap 1 116,036 165,430 353,770 292,805 625,823 661,456 - -
Change - 42.57% 113.85% -17.23% 113.73% 5.69% - -
Enterprise Value (EV) 1 111,466 182,891 372,593 298,611 629,170 658,254 631,472 598,228
Change - 64.08% 103.72% -19.86% 110.7% 4.62% -4.07% -5.26%
P/E 12.6x 14.1x 20.4x 12.1x 22x 21.2x 19.1x 18x
PBR 1.53x 1.92x 3.47x 2.42x 4.38x 4.02x 3.57x 3.15x
PEG - 0.5x 0.4x 0.3x 1.3x 2.1x 1.8x 2.87x
Capitalization / Revenue 1.04x 1.25x 2.35x 1.79x 3.52x 3.24x 3x 2.86x
EV / Revenue 0.99x 1.38x 2.48x 1.83x 3.54x 3.22x 2.87x 2.59x
EV / EBITDA - 10.7x 15.2x 9.04x 15.9x 14.6x 12.5x 11.2x
EV / EBIT 10.3x 12x 16.5x 9.6x 16.7x 15.7x 13.6x 12.1x
EV / FCF 15.1x -9.14x 161x 16.3x 65.7x 24.3x 22x 18.8x
FCF Yield 6.64% -10.9% 0.62% 6.13% 1.52% 4.11% 4.55% 5.31%
Dividend per Share 2 40 62 102 160 200 225 243.3 256.7
Rate of return 1.58% 1.72% 1.32% 2.51% 1.47% 1.56% 1.69% 1.78%
EPS 2 200.7 255.8 376.9 525.4 617.7 680 752.5 799.6
Distribution rate 19.9% 24.2% 27.1% 30.5% 32.4% 33.1% 32.3% 32.1%
Net sales 1 112,069 132,426 150,356 163,269 177,654 204,133 220,233 231,333
EBITDA 1 - 17,036 24,554 33,045 39,629 44,950 50,600 53,500
EBIT 1 10,850 15,212 22,544 31,120 37,648 41,967 46,433 49,333
Net income 1 9,210 11,730 17,310 24,150 28,401 31,267 34,600 36,767
Net Debt 1 -4,570 17,461 18,823 5,806 3,347 -3,202 -29,984 -63,229
Reference price 2 2,532.50 3,605.00 7,700.00 6,370.00 13,610.00 14,385.00 14,385.00 14,385.00
Nbr of stocks (in thousands) 45,819 45,889 45,944 45,966 45,983 45,982 - -
Announcement Date 12/05/22 12/05/23 13/05/24 13/05/25 13/05/26 - - -
1JPY in Million2JPY
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
21.16x3.22x14.64x1.56% 4.07B
23.2x2.99x15.96x1.33% 10.48B
60.38x3.93x24.73x - 4.67B
29.8x - - - 1.38B
47.9x3.12x26.82x - 922M
Average 36.48x 3.31x 20.54x 1.45% 4.3B
Weighted average by Cap. 32.36x 3.26x 18.22x 1.4%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. 6368 Stock
  4. Valuation Organo Corporation